RAASi and Hyperkalaemia in Cardio Renal Disease

Episodes 1-3 of 3

• 

  RestartResume

  Managing hyperkalemia in cardiorenal patients: novel therapeutic insights to optimize outcomes

  RestartResume

  Managing hyperkalemia in cardiorenal patients: novel therapeutic insights to optimize outcomes

  RAASi and Hyperkalaemia in Cardio Renal Disease

  Managing hyperkalemia in cardiorenal patients: novel therapeutic insights to optimize outcomes

  • 

    

    Prof. Matthew Weir, MD

• 

  RestartResume

  Addressing the risk of hyperkalemia in HF: is there a sweet spot for potassium binding?

  RestartResume

  Addressing the risk of hyperkalemia in HF: is there a sweet spot for potassium binding?

  RAASi and Hyperkalaemia in Cardio Renal Disease

  Addressing the risk of hyperkalemia in HF: is there a sweet spot for potassium binding?

  • 

    

    Prof. van der Meer, MD, PhD

• 

  RestartResume

  RAAS inhibition in patients with kidney disease: Balancing the benefits and risks

  RestartResume

  RAAS inhibition in patients with kidney disease: Balancing the benefits and risks

  RAASi and Hyperkalaemia in Cardio Renal Disease

  RAAS inhibition in patients with kidney disease: Balancing the benefits and risks

  • 

    

    Prof. Patrick Rossignol, MD